Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy

Background. To obtain new insights into the activation of the thyroid-stimulating hormone (TSH) and insulin-like growth factor 1 (IGF-1) receptors in human orbital fibroblasts (n-HOFs), the effects of the prostanoid EP2 agonist, omidenepag (OMD), and a rho-associated coiled-coil-containing protein k...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yosuke Ida, Hanae Ichioka, Masato Furuhashi, Fumihito Hikage, Megumi Watanabe, Araya Umetsu, Hiroshi Ohguro
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/c153308afa234843a145a51e10e3f285
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c153308afa234843a145a51e10e3f285
record_format dspace
spelling oai:doaj.org-article:c153308afa234843a145a51e10e3f2852021-11-25T17:12:44ZReactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy10.3390/cells101131962073-4409https://doaj.org/article/c153308afa234843a145a51e10e3f2852021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3196https://doaj.org/toc/2073-4409Background. To obtain new insights into the activation of the thyroid-stimulating hormone (TSH) and insulin-like growth factor 1 (IGF-1) receptors in human orbital fibroblasts (n-HOFs), the effects of the prostanoid EP2 agonist, omidenepag (OMD), and a rho-associated coiled-coil-containing protein kinase (ROCK) inhibitor, ripasudil (Rip) were evaluated using three-dimension (3D) n-HOFs spheroids in the absence and presence of the recombinant human TSH receptor antibodies, M22 and IGF-1. Methods. The effects of 100 nM OMD or 10 μM Rip on the physical properties, size, stiffness, and mRNA expression of several extracellular matrix (ECM) molecules, their regulator, inflammatory cytokines, and endoplasmic reticulum (ER) stress-related factors were examined and compared among 3D spheroids of n-HOFs, M22-/IGF-1-activated n-HOFs and GO-related human orbital fibroblasts (GHOFs). Results. The physical properties and mRNA expressions of several genes of the 3D n-HOFs spheroids were significantly and diversely modulated by the presence of OMD or Rip. The OMD-induced effects on M22-/IGF-1-activated n-HOFs were similar to the effects caused by GHOHs, but quite different from those of n-HOFs. Conclusions. The findings presented herein indicate that the changes induced by OMD may be useful in distinguishing between n-HOFs and GHOFs.Yosuke IdaHanae IchiokaMasato FuruhashiFumihito HikageMegumi WatanabeAraya UmetsuHiroshi OhguroMDPI AGarticleprostanoid EP2 agonistROCK inhibitorthree-dimension (3D) cell cultureGraves’ orbitopathyIGF-1orbital fibroblastBiology (General)QH301-705.5ENCells, Vol 10, Iss 3196, p 3196 (2021)
institution DOAJ
collection DOAJ
language EN
topic prostanoid EP2 agonist
ROCK inhibitor
three-dimension (3D) cell culture
Graves’ orbitopathy
IGF-1
orbital fibroblast
Biology (General)
QH301-705.5
spellingShingle prostanoid EP2 agonist
ROCK inhibitor
three-dimension (3D) cell culture
Graves’ orbitopathy
IGF-1
orbital fibroblast
Biology (General)
QH301-705.5
Yosuke Ida
Hanae Ichioka
Masato Furuhashi
Fumihito Hikage
Megumi Watanabe
Araya Umetsu
Hiroshi Ohguro
Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
description Background. To obtain new insights into the activation of the thyroid-stimulating hormone (TSH) and insulin-like growth factor 1 (IGF-1) receptors in human orbital fibroblasts (n-HOFs), the effects of the prostanoid EP2 agonist, omidenepag (OMD), and a rho-associated coiled-coil-containing protein kinase (ROCK) inhibitor, ripasudil (Rip) were evaluated using three-dimension (3D) n-HOFs spheroids in the absence and presence of the recombinant human TSH receptor antibodies, M22 and IGF-1. Methods. The effects of 100 nM OMD or 10 μM Rip on the physical properties, size, stiffness, and mRNA expression of several extracellular matrix (ECM) molecules, their regulator, inflammatory cytokines, and endoplasmic reticulum (ER) stress-related factors were examined and compared among 3D spheroids of n-HOFs, M22-/IGF-1-activated n-HOFs and GO-related human orbital fibroblasts (GHOFs). Results. The physical properties and mRNA expressions of several genes of the 3D n-HOFs spheroids were significantly and diversely modulated by the presence of OMD or Rip. The OMD-induced effects on M22-/IGF-1-activated n-HOFs were similar to the effects caused by GHOHs, but quite different from those of n-HOFs. Conclusions. The findings presented herein indicate that the changes induced by OMD may be useful in distinguishing between n-HOFs and GHOFs.
format article
author Yosuke Ida
Hanae Ichioka
Masato Furuhashi
Fumihito Hikage
Megumi Watanabe
Araya Umetsu
Hiroshi Ohguro
author_facet Yosuke Ida
Hanae Ichioka
Masato Furuhashi
Fumihito Hikage
Megumi Watanabe
Araya Umetsu
Hiroshi Ohguro
author_sort Yosuke Ida
title Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
title_short Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
title_full Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
title_fullStr Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
title_full_unstemmed Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
title_sort reactivities of a prostanoid ep2 agonist, omidenepag, are useful for distinguishing between 3d spheroids of human orbital fibroblasts without or with graves’ orbitopathy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c153308afa234843a145a51e10e3f285
work_keys_str_mv AT yosukeida reactivitiesofaprostanoidep2agonistomidenepagareusefulfordistinguishingbetween3dspheroidsofhumanorbitalfibroblastswithoutorwithgravesorbitopathy
AT hanaeichioka reactivitiesofaprostanoidep2agonistomidenepagareusefulfordistinguishingbetween3dspheroidsofhumanorbitalfibroblastswithoutorwithgravesorbitopathy
AT masatofuruhashi reactivitiesofaprostanoidep2agonistomidenepagareusefulfordistinguishingbetween3dspheroidsofhumanorbitalfibroblastswithoutorwithgravesorbitopathy
AT fumihitohikage reactivitiesofaprostanoidep2agonistomidenepagareusefulfordistinguishingbetween3dspheroidsofhumanorbitalfibroblastswithoutorwithgravesorbitopathy
AT megumiwatanabe reactivitiesofaprostanoidep2agonistomidenepagareusefulfordistinguishingbetween3dspheroidsofhumanorbitalfibroblastswithoutorwithgravesorbitopathy
AT arayaumetsu reactivitiesofaprostanoidep2agonistomidenepagareusefulfordistinguishingbetween3dspheroidsofhumanorbitalfibroblastswithoutorwithgravesorbitopathy
AT hiroshiohguro reactivitiesofaprostanoidep2agonistomidenepagareusefulfordistinguishingbetween3dspheroidsofhumanorbitalfibroblastswithoutorwithgravesorbitopathy
_version_ 1718412616656748544